Your browser doesn't support javascript.
loading
[Temporary suspension of AstraZeneca's vaccine; a reconstruction]. / Prikpauze AstraZeneca proportioneel?
Maas, D P M S M; Kramers, C; Smit, H J C A; Middeldorp, S; Helsloot, I.
Afiliación
  • Maas DPMSM; Radboudumc, afd. Interne Geneeskunde, Nijmegen.
  • Kramers C; Contact: D.P.M.S.M. Maas (dominique.maas@radboudumc.nl).
  • Smit HJCA; Radboudumc, afd. Interne Geneeskunde, Nijmegen(tevens: afd. Farmacologie-Toxicologie en Canisius Wilhelmina Ziekenhuis, afd. Klinische Farmacie, Nijmegen).
  • Middeldorp S; Canisius Wilhelmina Ziekenhuis, afd. Klinische Farmacie, Nijmegen.
  • Helsloot I; Radboudumc, afd. Interne Geneeskunde, Nijmegen.
Ned Tijdschr Geneeskd ; 1652021 04 28.
Article en Nl | MEDLINE | ID: mdl-33914428
ABSTRACT
In the middle of the worldwide COVID-19 crisis, the whole of Europe was alarmed about a possible side effect of the AstraZeneca vaccine against COVID-19. Consequently, the use of this AstraZeneca vaccine was temporarily suspended in many European nations including the Netherlands. In this article, we chronologically describe the decisions that were made about the use of this vaccine in the Netherlands and we discuss the risk-benefit ratios of these actions as well as possible non-medical reasons that may explain why these actions were taken.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: Nl Revista: Ned Tijdschr Geneeskd Año: 2021 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: Nl Revista: Ned Tijdschr Geneeskd Año: 2021 Tipo del documento: Article